THE EXPRESSION AND PROGNOSTIC VALUE OF PROGRAMMED DEATH-LIGAND 1 IN PROSTATE NEEDLE BIOPSY TISSUE OF PROSTATE CANCER PATIENTS UNDERGOING PRIMARY RADIATION THERAPY

被引：0
|
作者：
Shim, Kanghee
Kwon, Jieun
Yoo, Heejae
Park, Sunggon
Choo, Seolho
Choi, Jongbo
Ahn, Hyunsu
Kim, Sejoong
Kim, Sunil
机构：
来源：
JOURNAL OF UROLOGY | 2020年 / 203卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
MP16-08
引用
收藏
页码：E217 / E217
页数：1
相关论文
共 50 条
  • [21] Prognostic value of programmed death-ligand 1 in sarcoma: a meta-analysis
    Zhu, Zhenhua
    Jin, Zheng
    Zhang, Mei
    Tang, Yajun
    Yang, Guang
    Yuan, Xiaowei
    Yao, Jihang
    Sun, Dahui
    ONCOTARGET, 2017, 8 (35) : 59570 - 59580
  • [22] Prognostic role of programmed death-ligand 1 expression in patients with biliary tract cancer: a meta-analysis
    Lei, Changjiang
    Peng, Xiulan
    Gong, Xiaojun
    Fan, Ying
    Wu, Shenglin
    Liu, Ning
    Li, Lei
    Huang, Jianbin
    Zheng, Gang
    Long, Zhixiong
    AGING-US, 2019, 11 (24): : 12568 - 12580
  • [23] Evidence of Programmed Death-Ligand 1 Expression in a Highly Inflammatory Prostate: A Literature Review and Our Experience
    Koleva, Maria
    Mollova-Kyosebekirova, Angelina
    Dikov, Dorian
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (08)
  • [24] Implementation of programmed death-ligand 1 (PD-L1) expression as a prognostic biomarker for patients with lung cancer
    Li, Huijuan
    Lin, Dang
    Lv, Tangfeng
    TRANSLATIONAL LUNG CANCER RESEARCH, 2022,
  • [25] Prognostic Significance of the Dynamic Change of Programmed Death-ligand 1 Expression in Patients with Multiple Myeloma
    Guan, Jian
    Wang, Renching
    Hasan, Syed
    Tao, Luwei
    Wazir, Mohammed
    Jain, Akriti G.
    Zhu, Xiang
    Perkins, Sherrie
    Mohamed, Salama
    Chang, Chung-Che
    Mori, Shahram
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2019, 11 (04)
  • [26] Methylseleninic acid overcomes programmed death-ligand 1-mediated resistance of prostate cancer and lung cancer
    Hu, Wenli
    Ma, Yurong
    Zhao, Chong
    Yin, Shutao
    Hu, Hongbo
    MOLECULAR CARCINOGENESIS, 2021, 60 (11) : 746 - 757
  • [27] Prognostic Value of Programmed Death Ligand 1 and Programmed Death 1 Expression in Thymic Carcinoma
    Yokoyama, Shintaro
    Miyoshi, Hiroaki
    Nakashima, Kazutaka
    Shimono, Joji
    Hashiguchi, Toshihiro
    Mitsuoka, Masahiro
    Takamori, Shinzo
    Akagi, Yoshito
    Ohshima, Koichi
    CLINICAL CANCER RESEARCH, 2016, 22 (18) : 4727 - 4734
  • [28] Prognostic Value of Serum Soluble Programmed Death-Ligand 1 and Dynamics During Chemotherapy in Advanced Gastric Cancer Patients
    Park, Woochan
    Bang, Ju-Hee
    Nam, Ah-Rong
    Jin, Mei Hua
    Seo, Hyerim
    Kim, Jae-Min
    Oh, Kyoung Seok
    Kim, Tae-Yong
    Oh, Do-Youn
    CANCER RESEARCH AND TREATMENT, 2021, 53 (01): : 199 - 206
  • [29] Clinical characteristics of Korean lung cancer patients with programmed death-ligand 1 expression
    Park, H-Y.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (04) : S25 - S25
  • [30] Comparison of programmed death-ligand 1 protein expression between primary and metastatic lesions in patients with lung cancer
    Moutafi, Myrto K.
    Tao, Weiwei
    Huang, Richard
    Haberberger, James
    Alexander, Brian
    Ramkissoon, Shakti
    Ross, Jeffrey S.
    Syrigos, Konstantinos
    Wei, Wei
    Pusztai, Lajos
    Rimm, David L.
    Vathiotis, Ioannis A.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 (04)
12345